ACTC rumor on Yahoo Message Broad is: Partnership, Lanza/Langer(NVIV/ACTC) might just have the lead in regenerative medicine when combining ACTC's 'HEMANGIO-COLONY FORMING CELLS' and NVIV's scaffolding device. It's not likely. Why? Because both need money very soon. Say they do partner, who's going to pay for the trials? Both need MONEY.
I sold a few shares of ACTC at 11 cents today [the shares a bought at .105] made a little money. Will buy again around 10 cents. ACTC closed at .1070, the range for today was .11-.1035, volume was 9.5 million shares, ten day avg is 33.2 million shares.
Geron closed down 2 cents at $2.05 volume was only 456,731 shares, ten day avg. is 1,391,444 shares. Looks like no one knows any thing good or bad. Hoping Chip will say some thing Feb 14th, it will be webcasted.
Good luck in this rigged casino,
No comments:
Post a Comment